Braskem Nears Judicial Reorganization as Restructuring Talks Stall
BAK is trading near its 52-week low of $2.2 (7.3% above the low).
Summary
Braskem disclosed that debt restructuring negotiations have stalled, and with a creditor protection deadline looming, the company is moving closer to a judicial reorganization that its controlling shareholders now support.
Key Events · Legal and Risk Events · BAK
-
Restructuring Talks Fail
Despite months of negotiations, Braskem has not reached a consensual debt restructuring agreement with creditors, and with fewer than 30 days remaining on a court-ordered stay of enforcement actions, the company is moving closer to judicial reorganization.
-
Shareholders Back Judicial Reorganization
According to the filing, Braskem's controlling shareholders now view judicial reorganization as the best alternative to preserve the company and its assets, signaling a likely bankruptcy filing.
-
Creditor Proposals Under Review
Indicative, non-binding proposals from creditor groups include a possible capitalization (equity injection) and granting of security interests over assets as collateral, but no decisions have been made.
-
Imminent Deadline
The precautionary injunction staying creditor collection and enforcement actions expires in less than 30 days, creating an urgent timeline for a resolution.
Analysis · BAK · Industrial Applications And Services
With fewer than 30 days left on a court-ordered stay of creditor enforcement actions, Braskem has failed to reach a consensual debt restructuring deal. The company now acknowledges that its controlling shareholders view judicial reorganization as the best path to preserve the business. Creditor proposals include a possible equity injection and asset collateral, but no terms have been agreed. This filing confirms the company is on the brink of a formal bankruptcy process, which would likely wipe out existing equity holders.
At the time of this filing, BAK was trading at $2.36 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $848.3M. The 52-week trading range was $2.20 to $5.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.